Original Research

Published on 27 Sep 2022

Machine learning reveals two heterogeneous subtypes to assist immune therapy based on lipid metabolism in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Xuyu Gu
Shiyou Wei
Zhixin Li
Huan Xu

Frontiers in Immunology

doi 10.3389/fimmu.2022.1022149

2,312 views
2 citations

Original Research

Published on 27 Sep 2022

The immune microenvironment landscape shows treatment-specific differences in rectal cancer patients

in Cancer Immunity and Immunotherapy

Cristina Graham Martínez
Yari Barella
Sonay Kus Öztürk
Marleen Ansems
Mark A.J Gorris
Shannon van Vliet
Corrie A.M Marijnen
Iris D Nagtegaal

Frontiers in Immunology

doi 10.3389/fimmu.2022.1011498

2,808 views
8 citations

Review

Published on 27 Sep 2022

Mechanism and strategies of immunotherapy resistance in colorectal cancer

in Cancer Immunity and Immunotherapy

Jiqi Shan
Dong Han
Chunyi Shen
Qingyang Lei
Yi Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2022.1016646

7,094 views
9 citations

Case Report

Published on 27 Sep 2022

Case report: Complete remission of bone metastasis from renal cell carcinoma in histopathological examination after treatment with immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Yohei Asano
Norio Yamamoto
Katsuhiro Hayashi
Akihiko Takeuchi
Shinji Miwa
Kentaro Igarashi
Takashi Higuchi
Yuta Taniguchi
Sei Morinaga
Takashi Horimoto

Frontiers in Immunology

doi 10.3389/fimmu.2022.980456

3,025 views
2 citations

Original Research

Published on 27 Sep 2022

Identification of four immune subtypes in locally advanced rectal cancer treated with neoadjuvant chemotherapy for predicting the efficacy of subsequent immune checkpoint blockade

in Cancer Immunity and Immunotherapy

Le He
Min Jin
Dan Jian
Bo Yang
Nan Dai
Yan Feng
He Xiao
Dong Wang

Frontiers in Immunology

doi 10.3389/fimmu.2022.955187

3,972 views

Original Research

Published on 27 Sep 2022

CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Yanli Liu
Wanmei Liang
Yabin Chang
Zehui He
Meijian Wu
Haozhi Zheng
Xinrong Ke
Minjia Lv
Qingqian Liu
Qinyu Liu

Frontiers in Immunology

doi 10.3389/fimmu.2022.950884

4,019 views
4 citations

Review

Published on 27 Sep 2022

Recent advances in CAR-T cells therapy for colorectal cancer

in Cancer Immunity and Immunotherapy

Xiaoling Qin
Fengjiao Wu
Chang Chen
Qi Li

Frontiers in Immunology

doi 10.3389/fimmu.2022.904137

8,215 views
5 citations

Review

Published on 26 Sep 2022

What is the optimal duration of immune checkpoint inhibitors in malignant tumors?

in Cancer Immunity and Immunotherapy

Jiaxin Yin
Yuxiao Song
Jiazhuo Tang
Bicheng Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2022.983581

8,273 views
8 citations

Original Research

Published on 26 Sep 2022

CAR-T manufactured from frozen PBMC yield efficient function with prolonged in vitro production

in Cancer Immunity and Immunotherapy

Julieta Abraham-Miranda
Meghan Menges
Reginald Atkins
Mike Mattie
Justyna Kanska
Joel Turner
Melanie J. Hidalgo-Vargas
Frederick L. Locke

Frontiers in Immunology

doi 10.3389/fimmu.2022.1007042

6,263 views

Original Research

Published on 26 Sep 2022

Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy

in Cancer Immunity and Immunotherapy

Miaomiao Gou
Niansong Qian
Yong Zhang
Lihui Wei
Qihuang Fan
Zhikuan Wang
Guanghai Dai

Frontiers in Immunology

doi 10.3389/fimmu.2022.950868

2,688 views
2 citations

Original Research

Published on 26 Sep 2022

Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM

in Cancer Immunity and Immunotherapy

Songshan Feng
Xisong Liang
Jing Li
Zeyu Wang
Hao Zhang
Ziyu Dai
Peng Luo
Zaoqu Liu
Jian Zhang
Xiaoxiong Xiao

Frontiers in Immunology

doi 10.3389/fimmu.2022.992855

4,053 views
4 citations

Review

Published on 26 Sep 2022

Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer

in Cancer Immunity and Immunotherapy

Huiru Zhang
Longyun Ye
Xianjun Yu
Kaizhou Jin
Weiding Wu

Frontiers in Immunology

doi 10.3389/fimmu.2022.956984

5,252 views
7 citations

Original Research

Published on 26 Sep 2022

Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma

in Cancer Immunity and Immunotherapy

Jiaqi Yang
Jian Zhang
Song Na
Zhizhou Wang
Hanshuo Li
Yuxin Su
Li Ji
Xin Tang
Jun Yang
Lu Xu

Frontiers in Immunology

doi 10.3389/fimmu.2022.994034

7,207 views
6 citations

Original Research

Published on 26 Sep 2022

Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma

in Cancer Immunity and Immunotherapy

Tao Wang
Yufeng Liu
Qing Li
Yang Luo
Dawei Liu
Bin Li

Frontiers in Immunology

doi 10.3389/fimmu.2022.999823

6,150 views
21 citations

Case Report

Published on 26 Sep 2022

Case Report: Successful engraftment of allogeneic hematopoietic stem cells using CAR-T cell therapy as the conditioning regimen in R/R Ph+ B cell acute lymphoblastic leukemia

in Cancer Immunity and Immunotherapy

Lu Han
Ran Zhao
Jingyi Yang
Yingling Zu
Yanyan Liu
Jian Zhou
Linlin Li
Zhenghua Huang
Jishuai Zhang
Quanli Gao

Frontiers in Immunology

doi 10.3389/fimmu.2022.965932

2,651 views
2 citations

Original Research

Published on 23 Sep 2022

A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Qilin Li
Weimin Chen
Qiuhui Li
Jing Mao
Xin Chen

Frontiers in Immunology

doi 10.3389/fimmu.2022.1019967

3,494 views
7 citations

Navigation group

Articles

Machine learning reveals two heterogeneous subtypes to assist immune therapy based on lipid metabolism in lung adenocarcinoma

The immune microenvironment landscape shows treatment-specific differences in rectal cancer patients

Mechanism and strategies of immunotherapy resistance in colorectal cancer

Case report: Complete remission of bone metastasis from renal cell carcinoma in histopathological examination after treatment with immune checkpoint inhibitors

Identification of four immune subtypes in locally advanced rectal cancer treated with neoadjuvant chemotherapy for predicting the efficacy of subsequent immune checkpoint blockade

CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma

Recent advances in CAR-T cells therapy for colorectal cancer

What is the optimal duration of immune checkpoint inhibitors in malignant tumors?

CAR-T manufactured from frozen PBMC yield efficient function with prolonged in vitro production

Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy

Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM

Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer

Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma

Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma

Case Report: Successful engraftment of allogeneic hematopoietic stem cells using CAR-T cell therapy as the conditioning regimen in R/R Ph+ B cell acute lymphoblastic leukemia

A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma